HIGHFDA DRUG

Merck Emend Recalled Due to Potential Metal Contamination

Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
December 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 12, 2025
Hazard Level
HIGH
Brands
EMEND, Merck Sharp & Dohme LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
EMEND, Merck Sharp & Dohme LLC
Product type
Prescription Medication
Model numbers
Lot #: Z014503, Exp 11/15/2027
UPC codes
0006-0461, 0006-0462, 0006-3862, 0006-0464, 0006-3066, 0006-0461-02, 0006-0461-01, 0006-0461-06 +7 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 12, 2025

  2. Reported by FDA DRUG

    December 31, 2025

  3. RecallRadar source check

    January 7, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of particulate matter: potential presence of metal particulates in the product.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Merck Sharp & Dohme LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Merck Emend (aprepitant) is a prescription medication used to prevent nausea and vomiting caused by chemotherapy. Patients typically use it as part of a treatment regimen for cancer.

Why This Is Dangerous

The recall is due to the potential presence of metal particulates in the oral suspension, which can pose serious health risks if ingested. Consumers may experience adverse health effects from consuming contaminated products.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers should stop using the medication immediately to avoid potential health risks. The recall may cause inconvenience for patients needing nausea control during chemotherapy.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your product to see if it is Z014503.
  2. Verify the expiration date; affected products expire on November 15, 2027.
  3. If unsure, consult your healthcare provider.

Where to find product info

The lot number and expiration date are usually found on the packaging or label of the medication.

What timeline to expect

Expect refund processing to take approximately 4 to 6 weeks after your request is submitted.

If the manufacturer is unresponsive

  • Contact Merck Sharp & Dohme LLC support directly.
  • Document all correspondence and attempts to resolve the issue.

How to prevent similar issues

  • When purchasing prescription medications, always check for recalls and safety alerts.
  • Consult healthcare providers about alternative medications if recalls occur.
  • Stay informed about product safety news through reliable health sources.

Documentation advice

Keep a record of purchase receipts and any correspondence regarding the recall for future reference.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled product is Merck Emend (aprepitant) for oral suspension, 125 mg, in a single-dose kit. The lot number is Z014503, and it expires on November 15, 2027. The product was distributed nationwide in the USA.

Key Facts

  • Recalled product: Emend (aprepitant) for oral suspension
  • Lot #: Z014503, Expiration: 11/15/2027
  • Recall date: December 12, 2025
  • Potential metal contamination hazard
  • Stop use immediately and contact healthcare provider

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: Z014503
Exp 11/15/2027
UPC Codes
0006-0461
0006-0462
0006-3862
+12 more
Affected States
ALL
Report Date
December 31, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more